Bristol Myers to pay $800 million to develop cancer drug

Bristol Myers Squibb said on Monday it will pay $800 million upfront and up to $8.4 billion to Sichuan Biokin Pharmaceutical to develop and commercialise one of the Chinese drug company’s cancer drugs outside China.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM